Testing for breast cancer genes BRCA-1 and 2 has been inaccessible to many women due to extremely high cost. Now a new $249 breast cancer gene test is available. Experts discuss whether this changes who should be tested and the ramifications of widespread testing.
- Annette Bar-Cohen, Executive Director, Center for Advocacy Training, National Breast Cancer Coalition
- Dr. Charis Eng, Professor and Chair, Genomic Medical Institute, Cleveland Clinic Lerner Research Institute